RxDoctor Payments Data

Kevin Grant, MD

Orthopaedic Trauma · Royal Oak, MINPI 1154537645

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $35,268 of the $36,639 with a category attached, or 96.3%. Medical Device Business Services, Inc. accounts for 90.6% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2019 at $31,026 and has fallen 98.8% since, to $376 in 2025.

$36,639in general payments, 2019–2025

Across 36 payments — averaging $1017.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$33K
  • Medartis Inc.$2K
  • Johnson & Johnson$404
  • Curvafix, Inc.$141
  • Si-bone, Inc.$127
  • Amgen$107
  • plus $477 from 6 others
$80,348in research payments, 2019–2025

Across 8 payments — averaging $10,044 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Stryker$80K

What the payments were for

  • Consulting fees$35,26896%
  • Travel & lodging$160%
  • Food & beverage$1,3554%

General payments by program year

19
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few orthopaedic trauma providers in Michiganto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$190,295
Medicare patients
294
Services billed
1,156

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ibuprofen23$155

Paid to pharmacies, not to this prescriber.

Other orthopaedic trauma in Royal Oak

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →